UFPT Shorts Retreat but Bears Hold a Meaningful Stake
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
UFP Technologies reports Q3 results on November 4 with short sellers pulling back materially from recent highs, yet the position remains large enough to be a genuine part of the story heading into the print.
The clearest positioning shift is in short interest. Bears have cut exposure by roughly 7% over the past week and nearly 10% over the past month, bringing short interest down to 12.5% of the free float. That is still a high absolute level for a mid-cap health care supplies name. The retreat has not been driven by a squeeze: availability is running at 153%, meaning there are roughly 1.5 shares available to borrow for every share already short. Borrowing costs are also negligible at 0.54%, barely changed on the week. The short score of 71.5 ranks in the bottom 5th percentile of the ORTEX universe, flagging this as one of the more heavily scrutinised names in the market. Options positioning, by contrast, is notably calm. The put/call ratio of 0.54 is essentially in line with its 20-day average, only 0.3 standard deviations above the mean, suggesting options traders are not making a directional bet ahead of results.
The price tells its own story. UFPT has fallen 6.8% over the past month and lost a further 4.9% on the week, closing at $280.32. That pullback follows what was a strong run. A previous note flagged a year-to-date gain of nearly 27%, and the Q2 print in August triggered a one-day jump of more than 20%. The more recent quarterly result, in late October, produced a 3.2% decline on the day. So the stock has form for large post-earnings swings in both directions.
Institutional ownership adds an interesting layer to this setup. Neuberger Berman crossed the 5% threshold and filed a 13G in July, disclosing a 6.9% stake, up from 4.5% at its prior filing. American Century added 154,000 shares in the most recent quarter, and T. Rowe Price added 110,000. Those are meaningful additions for a company with roughly 7.7 million shares outstanding. On the other side, insider activity since August has been uniformly negative. Executive Chairman R. Jeffrey Bailly sold more than $4 million of stock in a single day in August, and two directors made further open-market sales in the weeks that followed. The 90-day net insider position amounts to a disposal of roughly 41,000 shares worth $12.9 million. None of these trades were made under a 10b5-1 plan, making them discretionary rather than scheduled. Wasatch Advisors, a long-term 13G filer, also trimmed its stake from 8.8% to 7.1% as of its October filing.
Wikipedia page traffic for UFP Technologies registered a z-score of 3.1 against its own 90-day history as of mid-October, well above the norm, though this dataset carries no measured relationship to the company's financial results and is best read as a signal of elevated retail attention rather than a guide to the print.
The earnings report will test whether the momentum that drove a 20% one-day gain in August was a durable re-rating or a one-quarter event, against a backdrop where large institutional buyers and significant short sellers are positioned on opposite sides of the same stock.
Stocks in this article
See the live data behind this article on ORTEX.
Open UFPT on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 04:19
- Data as of
- 4 Nov 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.